Non-coding RNA in immunotherapies and immune regulation PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Non-coding RNA in immunotherapies and immune regulation PDF full book. Access full book title Non-coding RNA in immunotherapies and immune regulation by Bertrand Kaeffer. Download full books in PDF and EPUB format.
Author: Bertrand Kaeffer
Publisher: Frontiers Media SA
ISBN: 2832510361
Category : Medical
Languages : en
Pages : 203
Get Book Here
Book Description
Author: Bertrand Kaeffer
Publisher: Frontiers Media SA
ISBN: 2832510361
Category : Medical
Languages : en
Pages : 203
Get Book Here
Book Description
Author: Alfons Navarro
Publisher: Humana
ISBN: 9781071615836
Category : Medical
Languages : en
Pages : 0
Get Book Here
Book Description
This volume presents techniques needed for the study of long non-coding RNAs (lncRNAs) in cancer from their identification to functional characterization. Chapters guide readers through identification of lncRNA expression signatures in cancer tissue or liquid biopsies by RNAseq, single Cell RNAseq, Phospho RNAseq or Nanopore Sequencing techniques; validation of lncRNA signatures by Real time PCR, digital PCR or in situ hybridization; and functional analysis by siRNA or CRISPR based methods for lncRNA silencing or overexpression. Lipid based nanoparticles for delivery of siRNAs in vivo, lncRNA-protein interactions, viral lncRNAs and circRNAs are also treated in this volume. Written in the format of the highly successful Methods in Molecular Biology series, each chapter includes an introduction to the topic, lists necessary materials and reagents, includes tips on troubleshooting and known pitfalls, and step-by-step, readily reproducible protocols. Authoritative and practical, Long Non-Coding RNAs in Cancer aims to provide a collection of laboratory protocols, bioinformatic pipelines, and review chapters to further research in this vital field.
Author: Yanyan Tang
Publisher: Frontiers Media SA
ISBN: 2889769577
Category : Science
Languages : en
Pages : 446
Get Book Here
Book Description
Author: Chunquan Li
Publisher: Frontiers Media SA
ISBN: 2832508219
Category : Medical
Languages : en
Pages : 148
Get Book Here
Book Description
Author: Mingzhu Yin
Publisher: Frontiers Media SA
ISBN: 2889762467
Category : Medical
Languages : en
Pages : 263
Get Book Here
Book Description
Author: Desi Shang
Publisher: Frontiers Media SA
ISBN: 2889746313
Category : Medical
Languages : en
Pages : 191
Get Book Here
Book Description
Author: Olanrewaju B. Morenikeji
Publisher: Frontiers Media SA
ISBN: 2832528015
Category : Science
Languages : en
Pages : 212
Get Book Here
Book Description
Author: Tim F. Greten
Publisher: Springer
ISBN: 9783319879116
Category : Medical
Languages : en
Pages : 0
Get Book Here
Book Description
In this book we provide insights into liver – cancer and immunology. Experts in the field provide an overview over fundamental immunological questions in liver cancer and tumorimmunology, which form the base for immune based approaches in HCC, which gain increasing interest in the community due to first promising results obtained in early clinical trials. Hepatocellular carcinoma (HCC) is the third most common cause of cancer related death in the United States. Treatment options are limited. Viral hepatitis is one of the major risk factors for HCC, which represents a typical “inflammation-induced” cancer. Immune-based treatment approaches have revolutionized oncology in recent years. Various treatment strategies have received FDA approval including dendritic cell vaccination, for prostate cancer as well as immune checkpoint inhibition targeting the CTLA4 or the PD1/PDL1 axis in melanoma, lung, and kidney cancer. Additionally, cell based therapies (adoptive T cell therapy, CAR T cells and TCR transduced T cells) have demonstrated significant efficacy in patients with B cell malignancies and melanoma. Immune checkpoint inhibitors in particular have generated enormous excitement across the entire field of oncology, providing a significant benefit to a minority of patients.
Author: Jian-Guo Zhou
Publisher: Frontiers Media SA
ISBN: 2889666093
Category : Medical
Languages : en
Pages : 599
Get Book Here
Book Description
Author: Chang Gu
Publisher: Frontiers Media SA
ISBN: 2832529275
Category : Science
Languages : en
Pages : 191
Get Book Here
Book Description
During the past few decades, immunotherapy has become an established pillar of cancer treatment improving the survival of numerous patients with diverse solid and hematologic tumors. The leading causes behind the success are the discovery of immune checkpoint inhibitors (ICIs) and the development of chimeric antigen receptor (CAR) T/M/NK cells. As for ICIs, malignancies take advantage of the inhibitory programmed cell death protein 1/programmed cell death protein ligand 1 (PD-1/PD-L1) or cytotoxic T-lymphocyte-associated protein (CTLA-4) pathways to evade the immune system, and disruption of the axis by immune checkpoint inhibitors can achieve durable disease remissions, which has been proved by basic researches and (pre-) clinical studies among lung cancer, melanoma, renal cell cancer, head, and neck squamous cell carcinoma, urothelial cancer, and Hodgkin’s disease. However, the 5-year survival rate of patients treated with ICIs varies with each individual and also relies on tumor specific pathological or molecular subtypes. Besides, the efficacy of ICIs is still limited in terms of drug resistance and fewer potential responders. Thus, there is a big challenge to identify and develop more novel reliable ICIs, as well as sensibilize existing ICIs for patients with drug resistance or even for non-responders.
